Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H22O2 |
Molecular Weight | 234.334 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC=C(C=O)[C@H](C=O)[C@@]1(C)CCCC2(C)C
InChI
InChIKey=AZJUJOFIHHNCSV-KCQAQPDRSA-N
InChI=1S/C15H22O2/c1-14(2)7-4-8-15(3)12(10-17)11(9-16)5-6-13(14)15/h5,9-10,12-13H,4,6-8H2,1-3H3/t12-,13-,15+/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/22217987Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16457780 | https://www.ncbi.nlm.nih.gov/pubmed/26360047 | https://www.ncbi.nlm.nih.gov/pubmed/20356305 | https://www.ncbi.nlm.nih.gov/pubmed/27645309
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22217987
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16457780 | https://www.ncbi.nlm.nih.gov/pubmed/26360047 | https://www.ncbi.nlm.nih.gov/pubmed/20356305 | https://www.ncbi.nlm.nih.gov/pubmed/27645309
Polygodial is a sesquiterpene dialdehyde isolated from the leaves of certain peppers and related plants, that exhibits anti-inflammatory, antiallergic, antinociceptive, anticancer, antifungal and antimicrobial activities. Polygodial’s primary antifungal action is as a nonionic surfactant, disrupting the lipid-protein interface of integral proteins nonspecifically, denaturing their functional conformation. It is also likely that Polygodial permeates by passive diffusion across the plasma membrane, and once inside the cells may react with a variety of intracellular compounds. Polygodial is a component of the “hot taste” in peppery spices of traditional Japanese cuisine.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4794 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26360047 |
|||
Target ID: CHEMBL6007 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20356305 |
59.0 nM [EC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Anti-hyperalgesic properties of the extract and of the main sesquiterpene polygodial isolated from the barks of Drymis winteri (Winteraceae). | 1998 |
|
In vitro antifungal susceptibilities of Candida albicans and other fungal pathogens to polygodial, a sesquiterpene dialdehyde. | 1999 Apr |
|
Assessment of mechanisms involved in antinociception caused by sesquiterpene polygodial. | 2000 Jan |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22217987
tablet twice a day of a K-712 (10 mg of oleoresin from Pseudowintera colorata at 30 percent concentration in Polygodial) for 4 weeks and then for the first 2 weeks of each month for a total of 6 months.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27645309
Mice beta-pancreatic insulinoma INS 1E cell line were used for activity evaluation. INS 1E cells (2 x 10^5/well) were seeded in 24-well plate and incubated in the same conditions of regular cell culture. Different polygodial concentrations (30, 300, 3000 nM, diluted in EtOH) stimulus were assessed for 1 h and 24 h of incubation in order to evaluate the acute and chronic effect of the compound, respectively. After growth and treatment with polygodial, cells were detached with trypsin and 1 mL of the PBS suspension and centrifuged. The cellular pellet was resuspended in 300 mkL of a 50 mkg/mL propidium iodide 0.1% hypotonic solution with sodium citrate 0.1% and Triton X-100 0.1%. Afterwards, samples were incubated for 30 min at 4 C and analyzed by flow cytometry in a FACScalibur system (BD Bioscience, San Jose, CA, USA).
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Polygodial
Created by
admin on Sat Dec 16 09:34:24 GMT 2023 , Edited by admin on Sat Dec 16 09:34:24 GMT 2023
|
PRIMARY | |||
|
A00RAV0W57
Created by
admin on Sat Dec 16 09:34:24 GMT 2023 , Edited by admin on Sat Dec 16 09:34:24 GMT 2023
|
PRIMARY | |||
|
33118-34-2
Created by
admin on Sat Dec 16 09:34:24 GMT 2023 , Edited by admin on Sat Dec 16 09:34:24 GMT 2023
|
PRIMARY | |||
|
m8960
Created by
admin on Sat Dec 16 09:34:24 GMT 2023 , Edited by admin on Sat Dec 16 09:34:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
72503
Created by
admin on Sat Dec 16 09:34:24 GMT 2023 , Edited by admin on Sat Dec 16 09:34:24 GMT 2023
|
PRIMARY | |||
|
DTXSID50954741
Created by
admin on Sat Dec 16 09:34:24 GMT 2023 , Edited by admin on Sat Dec 16 09:34:24 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD